advertisement

Topcon

Matamoros JA 17

Showing records 1 to 17 | Display all abstracts from Matamoros JA

116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Martínez-López MA
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Fernández-Albarral JA
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Rubio-Casado S
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Ramírez AI; de Hoz R
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
San Felipe D
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Matamoros JA
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Martín-Sánchez B; Fernández-Albarral JA
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Salobrar-García E
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Salobrar-García E
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Elvira-Hurtado L; López-Cuenca I
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Matamoros JA
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Sánchez-Puebla L
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Ramírez JM; de Hoz R
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Salazar JJ
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Salazar JJ
International journal of molecular sciences 2024; 25:
117271 Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Ramírez JM
Frontiers in cellular neuroscience 2024; 18: 1354569
116845 Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma
Marco EM; Ramírez AI; Lázaro A; López-Gallardo M
International journal of molecular sciences 2024; 25:

Issue 24-4

Change Issue


advertisement

Nidek